Related Experiment Videos
Clinical psychopharmacology for Tourette syndrome and associated disorders
1Department of Child Psychiatry, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Advances in Neurology
|September 4, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Localized myxedema histologically mimicking spindle cell lipoma.
Dermatology online journal·2022
Relationship between atrial fibrillatory rate based on analysis of a modified base-apex surface electrocardiogram analysis and the results of transvenous electrical cardioversion in horses with spontaneous atrial fibrillation.
Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2021
Clustering of Four-Component Unitary Fermions.
Physical review letters·2020
Aortocavitary fistula secondary to vegetative endocarditis in a rabbit.
Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2019
Interatrial block in prediction of all-cause mortality after first-ever ischemic stroke.
BMC cardiovascular disorders·2019
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.
The Journal of membrane biology·2026
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026